Welcome to this week's Chutes and Ladders, our roundup of hirings and firings throughout the industry. Please send the good word--or the bad--from your shop to Michael Gibney (email | Twitter) or Emily Mullin (email | Twitter) and we will feature it here at the end of each week.
Forest CEO Saunders to lead combined company after Actavis buyout
With Actavis ($ACT) poised to buy Forest Laboratories, the Irish company announced that Paul Bisaro, chairman and CEO of Actavis, will become executive chairman while Brent Saunders, currently CEO and president of Forest, will become CEO and president, and a member of the board of directors. Story | Release
|
||||
Biotech
> The TB Alliance appointed Nader Fotouhi as its chief scientific officer. Release
> Richard Rudick joined Biogen Idec ($BIIB) as the company's vice president of development sciences and value-based medicine. Release
> Marina Biotech named Daniel Geffken as its interim chief financial officer. Release
> Lisa Bell joined Coherus Biosciences as the company's senior vice president of global regulatory affairs. Release
> Genelux appointed former Amgen ($AMGN) executive Thomas Zindrick and former Abbott ($ABT) executive James Tyree as CEO and chairman of the board, respectively. Release
> Promethera Biosciences brought on Frank Hazevoets as its chief financial officer. Release
> Amgen ($AMGN) has named Dr. Steven Galson as senior vice president of global regulatory affairs and safety. Release
> Dr. Paul Friedman has joined Verastem's ($VSTM) board of directors. Release
> Transgenomic ($TBIO) has appointed John Thompson to its board of directors. Release
> Kite Pharma appointed Dr. Jeffrey Wiezorek as its vice president of clinical development. Release
Biotech IT
> Compugen ($CGEN) CFO Dikla Czaczkes Axselbrad has left the company. Compugen named Avihai Shen as interim CFO. Release
Pharma
> Charleston Laboratories named Joseph Hazelton to the newly created position of executive vice president and chief commercial officer, and Michael McCully joined the company in the newly created position of executive vice president, chief financial and business officer. Release
Medical Devices
> AxoGen ($AXGN) appointed Lee Robert Johnston as its chief financial officer. Release
> Medacta International has named Eric Dremel as president of the company's U.S. subsidiary, Medacta USA. Release
> Keystone Heart announced that Hank Hauser has joined the company as vice president of its clinical operations. Release